At the time of writing, Unitedhealth Group Inc [UNH] stock is trading at $351.81, up 1.18%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The UNH shares have gain 2.99% over the last week, with a monthly amount glided 15.40%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Unitedhealth Group Inc [NYSE: UNH] stock has seen the most recent analyst activity on July 31, 2025, when Robert W. Baird downgraded its rating to a Underperform but kept the price target unchanged to $198 for it. Previously, Oppenheimer reaffirmed its Outperform rating on July 30, 2025, and dropped its price target to $325. On June 11, 2025, downgrade downgraded it’s rating to Neutral but maintained its price target of $312 on the stock. HSBC Securities downgraded its rating to a Reduce but stick to its price target of $270 on May 21, 2025. TD Cowen downgraded its rating to a Hold but $308 remained the price target by the analyst firm on May 19, 2025. Raymond James downgraded its rating to Mkt Perform for this stock on May 14, 2025. In a note dated May 14, 2025, BofA Securities downgraded an Neutral rating on this stock but restated the target price of $350.
For the past year, the stock price of Unitedhealth Group Inc fluctuated between $234.60 and $630.73. Currently, Wall Street analysts expect the stock to reach $355.08 within the next 12 months. Unitedhealth Group Inc [NYSE: UNH] shares were valued at $351.81 at the most recent close of the market. An investor can expect a potential return of 0.93% based on the average UNH price forecast.
Analyzing the UNH fundamentals
According to Unitedhealth Group Inc [NYSE:UNH], the company’s sales were 422.82B for trailing twelve months, which represents an 12.91% jump. Gross Profit Margin for this corporation currently stands at 0.21% with Operating Profit Margin at 0.07%, Pretax Profit Margin comes in at 0.06%, and Net Profit Margin reading is 0.05%. To continue investigating profitability, this company’s Return on Assets is posted at 0.07, Equity is 0.22 and Total Capital is 0.16. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.79.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 348.27 points at the first support level, and at 344.72 for the second support level. However, for the 1st resistance point, the stock is sitting at 354.93, and for the 2nd resistance point, it is at 358.04.
Ratios To Look Out For
It is important to note that Unitedhealth Group Inc [NYSE:UNH] has a current ratio of 0.85. Considering the valuation of this stock, the price to sales ratio is 0.75, the price to book ratio is 3.36 and price to earnings (TTM) ratio is 15.24.
Transactions by insiders
Recent insider trading involved Baker Charles D., Director, that happened on Sep 11 ’25 when 27.0 shares were sold. Affiliate, James P Schadt Trust FBO Laure completed a deal on Sep 11 ’25 to buy 27.0 shares. Meanwhile, Chief Executive Officer, Optum Conway Patrick Hugh sold 589.0 shares on Jun 10 ’25.
